
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
PFE | Stockholm | SEK | Real-time | |
PFE | Frankfurt | EUR | Delayed | |
PFE | TradeGate | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | BM&FBovespa | BRL | Delayed | |
PFE | Vienna | EUR | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
By Senad Karaahmetovic Bank of America strategist Anthony Cassamassino listed 10 high-conviction stocks for the third quarter that started today. The list consists of 9 long and 1...
Pfizer, Inc. (NYSE: PFE) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the full approval of Paxlovid, its antiviral pill for...
Pfizer Inc (NYSE: PFE) has submitted a new drug application to the FDA for the approval of Paxlovid for patients at high risk for progression to severe illness from...
EU President 'Can't Find' Texts With Pfizer Chief Discussing COVID-19 Vaccine In April 2021, European Commission president Ursula von der Leyen revealed that she had been texting...
Biden Admin Inks $3.2 Billion Deal With Pfizer For 105 Million COVID-19 Vaccines Authored by Tom Ozimek via The Epoch Times (emphasis ours), The Biden administration said it has...
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled studies completed to date, oral brepocitinib generated...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | - | - | - | - | - |
Technical Indicators | - | - | - | - | - |
Summary | Neutral | Neutral | Neutral | Neutral | Neutral |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Bullish Hammer | 1H | Current | |||
Completed Patterns | |||||
Engulfing Bearish | 1D | 1 | Feb 24, 2022 | ||
Three Outside Down | 30 | 2 | Feb 25, 2022 04:00 | ||
Abandoned Baby Bullish | 1M | 3 | Nov 2021 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NYSE | 52.31 | 51.80 | 52.00 | 16,143,272 | -0.23% | USD | 01/07 | ||
Mexico | 1,057.99 | 1,020.00 | 1,060.00 | 0 | +0.00% | MXN | 01/07 | ||
Stockholm | 541.5 | 0.0 | 0.0 | 5,592 | +0.46% | SEK | 11:29:13 | ||
Frankfurt | 50.20 | 50.20 | 50.30 | 2,691 | +0.64% | EUR | 10:55:00 | ||
TradeGate | 50.20 | 50.15 | 50.30 | 13,074 | +0.88% | EUR | 11:27:00 | ||
Hamburg | 49.72 | 0.00 | 0.00 | 0 | -0.20% | EUR | 08:01:00 | ||
Xetra | 50.250 | 50.250 | 50.350 | 11,017 | +0.30% | EUR | 11:06:52 | ||
Santiago | 49.37 | 0.00 | 0.00 | 74 | 0.00% | USD | 24/05 | ||
Buenos Aires | 7,050.00 | 7,037.50 | 7,050.00 | 1,486 | +6.96% | ARS | 04/07 | ||
BM&FBovespa | 68.59 | 66.06 | 69.70 | 2,824 | 0.00% | BRL | 00:45:00 | ||
Vienna | 49.980 | 0.000 | 0.000 | 143 | +0.64% | EUR | 04/07 | ||
KASE | 52.24 | 52.24 | 52.40 | 1 | -0.55% | USD | 07:43:00 | ||
Colombia | 218,200.00 | 0.00 | 0.00 | 160 | +3.14% | COP | 30/06 | ||
Lima | 49.95 | 0.00 | 0.00 | 850 | -7.86% | USD | 23/06 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Vodacom | 13,258 | 13,595 | 13,213 | -319 | -2.35% | 175.32K | 11:13:00 | ||
Sasol | 36,700 | 37,225 | 36,479 | -600 | -1.61% | 262.73K | 11:13:00 | ||
Aveng Ltd | 1,500 | 1,510 | 1,476 | 0 | 0.00% | 16.12K | 11:09:00 | ||
Growthpoint Properties | 1,240 | 1,257 | 1,225 | +5 | +0.40% | 1.74M | 11:12:00 | ||
Mpact | 3,052 | 3,100 | 3,000 | +0 | +0.00% | 0 | 04/07 | ||
Avi | 6,621 | 6,701 | 6,590 | -9 | -0.14% | 37.06K | 11:11:00 | ||
RENERGEN | 3,623 | 3,700 | 3,623 | -72 | -1.95% | 23.64K | 11:13:00 | ||
Naspers | 261,755 | 263,699 | 254,894 | +6858 | +2.69% | 340.21K | 11:13:00 | ||
Fortress Income | 1,110 | 1,124 | 1,100 | -9 | -0.80% | 87.69K | 11:11:00 | ||
Cashbuild | 24,500 | 24,500 | 24,500 | -138 | -0.56% | 0.12K | 09:41:00 |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review